-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WKrq6N1M+1qGaX6BqTfNc8IrKMYUPjMwiouD9TJstvgtuDTXIcShC7dSjGTZZqHs DU02pi3y9D/3Rc86YtP7bA== 0001209191-09-051845.txt : 20091110 0001209191-09-051845.hdr.sgml : 20091110 20091110123633 ACCESSION NUMBER: 0001209191-09-051845 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20091101 FILED AS OF DATE: 20091110 DATE AS OF CHANGE: 20091110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conterno Enrique A CENTRAL INDEX KEY: 0001476151 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 091171063 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 3 1 doc3.xml FORM 3 SUBMISSION X0203 3 2009-11-01 0 0000059478 LILLY ELI & CO LLY 0001476151 Conterno Enrique A LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 Sr. VP, Diabetes Business Unit Common Stock 9392 D Common Stock 2919 I 401(k) Employee stock option 10/01 (right to buy) 79.28 2003-10-03 2011-10-04 Common Stock 4250 D Employee stock option 2/01 (right to buy) 73.98 2004-02-20 2011-02-18 Common Stock 9350 D Employee stock option 2/02 (right to buy) 75.92 2005-02-18 2012-02-17 Common Stock 10000 D Employee stock option 2/03 (right to buy) 57.85 2006-02-16 2013-02-15 Common Stock 10700 D Employee stock option 2/04 (right to buy) 73.11 2007-02-19 2014-02-14 Common Stock 10700 D Employee stock option 2/05 (right to buy) 55.65 2008-02-11 2015-02-10 Common Stock 7101 D Employee stock option 2/06 (right to buy) 56.18 2009-02-10 2016-02-09 Common Stock 6928 D Restricted Stock Unit 2013-05-01 2013-05-01 Common Stock 10000 D Restricted Stock Unit 2018-05-01 2018-05-01 Common Stock 20000 D Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Enrique A. Conterno 2009-11-09 EX-24.3_305023 2 poa.txt POA DOCUMENT Enrique A. Conterno Lilly Corporate Center Indianapolis, IN 46285 Securities and Exchange Commission Washington, D.C. 20549 Authorization Regarding Reporting Forms I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder: Robert A. Armitage, Lilly Corporate Center, Indianapolis, Indiana James B. Lootens, Lilly Corporate Center, Indianapolis, Indiana Bronwen L. Mantlo, Lilly Corporate Center, Indianapolis, Indiana This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission. October 29, 2009 Enrique A. Conterno -----END PRIVACY-ENHANCED MESSAGE-----